Cargando…

A highly efficacious pediculicide based on dimeticone: Randomized observer blinded comparative trial

BACKGROUND: Infestation with the human head louse (Pediculus humanus capitis) occurs worldwide. Existing treatment options are limited, and reports of resistance to commonly used pediculicides have been increasing. In this trial we assessed the efficacy of a product containing a high (92%) concentra...

Descripción completa

Detalles Bibliográficos
Autores principales: Heukelbach, Jorg, Pilger, Daniel, Oliveira, Fabíola A, Khakban, Adak, Ariza, Liana, Feldmeier, Hermann
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2008
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2553415/
https://www.ncbi.nlm.nih.gov/pubmed/18783606
http://dx.doi.org/10.1186/1471-2334-8-115
_version_ 1782159502997454848
author Heukelbach, Jorg
Pilger, Daniel
Oliveira, Fabíola A
Khakban, Adak
Ariza, Liana
Feldmeier, Hermann
author_facet Heukelbach, Jorg
Pilger, Daniel
Oliveira, Fabíola A
Khakban, Adak
Ariza, Liana
Feldmeier, Hermann
author_sort Heukelbach, Jorg
collection PubMed
description BACKGROUND: Infestation with the human head louse (Pediculus humanus capitis) occurs worldwide. Existing treatment options are limited, and reports of resistance to commonly used pediculicides have been increasing. In this trial we assessed the efficacy of a product containing a high (92%) concentration of the silicone oil dimeticone (identical in composition to NYDA(®)), as compared to a 1% permethrin lotion. METHODS: Randomized, controlled, observer blinded clinical trial. Participants were recruited from a poor urban neighbourhood in Brazil where pediculosis capitis was highly prevalent. To minimize reinfestation during the trial, participants (145 children aged 5–15 years with head lice infestations) were transferred to a holiday resort outside the endemic area for a period of 9 days. Two applications of dimeticone or 1% permethrin were done, seven days apart. Outcome measures were defined as cure (absence of vital head lice) after first application and before and after second applications, degree of itching, cosmetic acceptability, and clinical pathology. RESULTS: Overall cure rates were: day 2 – dimeticone 94.5% (95% CI: 86.6% – 98.5%) and permethrin 66.7% (95% CI: 54.6% – 77.3%; p < 0.0001); day 7 – dimeticone 64.4% (95% CI: 53.3% – 75.3%) and permethrin 59.7% (95% CI: 47.5% – 71.1%; p = 0.5); day 9 – dimeticone 97.2% (95% CI: 90.3% – 99.7%) and permethrin 67.6% (95% CI: 55.4%-78.2%); p < 0.0001). Itching was reduced similarly in both groups. Cosmetic acceptability was significantly better in the dimeticone group as compared to the permethrin group (p = 0.01). Two mild product-related incidents occurred in the dimeticone group. CONCLUSION: The dimeticone product is a safe and highly efficacious pediculicide. Due to its physical mode of action (interruption of the lice's oxygen supply of the central nervous system), development of resistance is unlikely. TRIAL REGISTRATION: Current Controlled Trials ISRCTN15117709.
format Text
id pubmed-2553415
institution National Center for Biotechnology Information
language English
publishDate 2008
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-25534152008-09-26 A highly efficacious pediculicide based on dimeticone: Randomized observer blinded comparative trial Heukelbach, Jorg Pilger, Daniel Oliveira, Fabíola A Khakban, Adak Ariza, Liana Feldmeier, Hermann BMC Infect Dis Research Article BACKGROUND: Infestation with the human head louse (Pediculus humanus capitis) occurs worldwide. Existing treatment options are limited, and reports of resistance to commonly used pediculicides have been increasing. In this trial we assessed the efficacy of a product containing a high (92%) concentration of the silicone oil dimeticone (identical in composition to NYDA(®)), as compared to a 1% permethrin lotion. METHODS: Randomized, controlled, observer blinded clinical trial. Participants were recruited from a poor urban neighbourhood in Brazil where pediculosis capitis was highly prevalent. To minimize reinfestation during the trial, participants (145 children aged 5–15 years with head lice infestations) were transferred to a holiday resort outside the endemic area for a period of 9 days. Two applications of dimeticone or 1% permethrin were done, seven days apart. Outcome measures were defined as cure (absence of vital head lice) after first application and before and after second applications, degree of itching, cosmetic acceptability, and clinical pathology. RESULTS: Overall cure rates were: day 2 – dimeticone 94.5% (95% CI: 86.6% – 98.5%) and permethrin 66.7% (95% CI: 54.6% – 77.3%; p < 0.0001); day 7 – dimeticone 64.4% (95% CI: 53.3% – 75.3%) and permethrin 59.7% (95% CI: 47.5% – 71.1%; p = 0.5); day 9 – dimeticone 97.2% (95% CI: 90.3% – 99.7%) and permethrin 67.6% (95% CI: 55.4%-78.2%); p < 0.0001). Itching was reduced similarly in both groups. Cosmetic acceptability was significantly better in the dimeticone group as compared to the permethrin group (p = 0.01). Two mild product-related incidents occurred in the dimeticone group. CONCLUSION: The dimeticone product is a safe and highly efficacious pediculicide. Due to its physical mode of action (interruption of the lice's oxygen supply of the central nervous system), development of resistance is unlikely. TRIAL REGISTRATION: Current Controlled Trials ISRCTN15117709. BioMed Central 2008-09-10 /pmc/articles/PMC2553415/ /pubmed/18783606 http://dx.doi.org/10.1186/1471-2334-8-115 Text en Copyright © 2008 Heukelbach et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Heukelbach, Jorg
Pilger, Daniel
Oliveira, Fabíola A
Khakban, Adak
Ariza, Liana
Feldmeier, Hermann
A highly efficacious pediculicide based on dimeticone: Randomized observer blinded comparative trial
title A highly efficacious pediculicide based on dimeticone: Randomized observer blinded comparative trial
title_full A highly efficacious pediculicide based on dimeticone: Randomized observer blinded comparative trial
title_fullStr A highly efficacious pediculicide based on dimeticone: Randomized observer blinded comparative trial
title_full_unstemmed A highly efficacious pediculicide based on dimeticone: Randomized observer blinded comparative trial
title_short A highly efficacious pediculicide based on dimeticone: Randomized observer blinded comparative trial
title_sort highly efficacious pediculicide based on dimeticone: randomized observer blinded comparative trial
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2553415/
https://www.ncbi.nlm.nih.gov/pubmed/18783606
http://dx.doi.org/10.1186/1471-2334-8-115
work_keys_str_mv AT heukelbachjorg ahighlyefficaciouspediculicidebasedondimeticonerandomizedobserverblindedcomparativetrial
AT pilgerdaniel ahighlyefficaciouspediculicidebasedondimeticonerandomizedobserverblindedcomparativetrial
AT oliveirafabiolaa ahighlyefficaciouspediculicidebasedondimeticonerandomizedobserverblindedcomparativetrial
AT khakbanadak ahighlyefficaciouspediculicidebasedondimeticonerandomizedobserverblindedcomparativetrial
AT arizaliana ahighlyefficaciouspediculicidebasedondimeticonerandomizedobserverblindedcomparativetrial
AT feldmeierhermann ahighlyefficaciouspediculicidebasedondimeticonerandomizedobserverblindedcomparativetrial
AT heukelbachjorg highlyefficaciouspediculicidebasedondimeticonerandomizedobserverblindedcomparativetrial
AT pilgerdaniel highlyefficaciouspediculicidebasedondimeticonerandomizedobserverblindedcomparativetrial
AT oliveirafabiolaa highlyefficaciouspediculicidebasedondimeticonerandomizedobserverblindedcomparativetrial
AT khakbanadak highlyefficaciouspediculicidebasedondimeticonerandomizedobserverblindedcomparativetrial
AT arizaliana highlyefficaciouspediculicidebasedondimeticonerandomizedobserverblindedcomparativetrial
AT feldmeierhermann highlyefficaciouspediculicidebasedondimeticonerandomizedobserverblindedcomparativetrial